NYSE:MRK (USA) Also Trade In: Argentina Austria Brazil Chile France Germany Mexico Romania Switzerland UK
Merck & Co Inc $ 75.89 -0.29 (-0.38%)
Warning! GuruFocus has detected 2 Medium warning signs with MRK. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Merck & Co Inc () from 1990 to Oct 30 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Merck & stock (MRK) PE ratio as of Oct 30 2020 is 16.79. More Details
Merck & PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Merck & PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NYSE:PFE NYSE:ABBV NYSE:LLY NYSE:BMY NAS:AMGN NAS:GILD NYSE:AGN NAS:BIIB NAS:HZNP NYSE:JNJ XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN LSE:GSK TSE:4519 FRA:A60 XTER:BAYN SHSE:600276 TSE:4568
Traded in other countries MRK.Argentina MRK.Austria MRCK34.Brazil MRK.Chile MRK.France 6MK.Germany MRK.Mexico MRK.Romania MRK.Switzerland 0QAH.UK MRK.USA
Address 2000 Galloping Hill Road, Kenilworth, NJ, USA, 07033
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.